Wealthfront Advisers’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-26,309
Closed -$5.58M – 878
2023
Q3
$5.58M Sell
26,309
-9,112
-26% -$1.82M 0.02% 193
2023
Q2
$6.82M Buy
35,421
+10,487
+42% +$2.08M 0.03% 170
2023
Q1
$5.05M Buy
24,934
+6,394
+34% +$1.03M 0.02% 204
2022
Q4
$2.38M Sell
18,540
-1,879
-9% -$243K 0.01% 363
2022
Q3
$2.79M Sell
20,419
-533
-3% -$86.8K 0.01% 287
2022
Q2
$3.71M Buy
20,952
+6,566
+46% +$946K 0.02% 243
2022
Q1
$2.07M Buy
14,386
+5,139
+56% +$695K 0.01% 393
2021
Q4
$1.43M Buy
9,247
+7,582
+455% +$1.27M 0.01% 446
2021
Q3
$283K Buy
+1,665
New +$259K ﹤0.01% 630

Other funds holding SGEN

Wealthfront Advisers's SGEN Position: Q4 2023 in Review

Wealthfront Advisers sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 26,309 shares — an estimated $5.58M sold.

Wealthfront Advisers first reported a position in SGEN in Q3 2021 and held it in 9 quarters. The position peaked at $6.82M in Q2 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Wealthfront Advisers reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Wealthfront Advisers sold 26,309 Seagen Inc. Common Stock shares in Q4 2023, an estimated $5.58M.
  • Wealthfront Advisers first reported a position in Seagen Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Wealthfront Advisers's Seagen Inc. Common Stock position peaked at $6.82M in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Wealthfront Advisers's 13F filing for Q4 2023, filed 9 Feb 2024.